ConductScience.org, home

Paper39216548

YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer.

Li B and 11 others. Cancer Lett, 2024. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer. Papers, record 39216548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39216548

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer.
PubMed
Journal
Cancer Lett
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
2.85, provisional
iCite
Revised in PubMed
2026-10-01
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li BBorui
2Xing FFaliang
3Wang JJingyi
4Wang XXiaohong
5Zhou CChenjie
6Fan GGuixiong
7Zhuo QQifeng
8Ji SShunrong
9Yu XXianjun
10Xu XXiaowu
11Qin YYi
12Li ZZheng

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
beta CateninMajor topic
Carcinoma, Pancreatic DuctalMajor topic
DeoxycytidineMajor topic
Drug Resistance, NeoplasmMajor topic
GemcitabineMajor topic
Low Density Lipoprotein Receptor-Related Protein-1Major topic
Pancreatic NeoplasmsMajor topic
Ribonucleoside Diphosphate ReductaseMajor topic
Y-Box-Binding Protein 1Major topic
Animals
Humans
Mice
Antimetabolites, Antineoplastic
Cell Line, Tumor
Cell Proliferation
Gene Expression Regulation, Neoplastic
Mice, Nude
Signal Transduction
Tumor Suppressor Proteins
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42957640Targeting PSMD14 increases chemotherapeutic sensitivity to gemcitabine by inhibiting the WNT/β-catenin pathway and glycolysis in pancreatic cancer.Cell Death Dis2026https://conductscience.org/library/papers/42957640PubMed
42698848YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance.Front Immunol2026https://conductscience.org/library/papers/42698848PubMed
42480704MOF promotes venous thromboembolism in lung cancer by activating the YBX1-MALT1-NF-κB-PAI-1 axis, possibly through histone crotonylation.J Biol Chem2026https://conductscience.org/library/papers/42480704PubMed
42312894Breaking Through the Limits: Nanomedicine at the Service of New Drug Combinations to Tackle Pancreatic Cancer.Wiley Interdiscip Rev Nanomed Nanobiotechnol2026https://conductscience.org/library/papers/42312894PubMed
42278514Age- and Treatment-Specific TP53 and PI3K Alterations in Pancreatic Ductal Adenocarcinoma (PDAC) Revealed by Conversational Artificial Intelligence.Int J Mol Sci2026https://conductscience.org/library/papers/42278514PubMed
42158236Interplay of RNA m6A/m1A/m5C/m7G/ψ Regulators Predicting the Prognosis of Pancreatic Cancer.FASEB Bioadv2026https://conductscience.org/library/papers/42158236PubMed
42052571Epigenetic regulation in cancer chemoresistance and combined therapeutic strategies.Front Cell Dev Biol2026https://conductscience.org/library/papers/42052571PubMed
41987290Uridine metabolism promotes lung adenocarcinoma progression by activating FBL transcription via YBX1.J Transl Med2026https://conductscience.org/library/papers/41987290PubMed
41513625RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway.Cell Death Discov2026https://conductscience.org/library/papers/41513625PubMed
41507134YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression.Cell Death Dis2026https://conductscience.org/library/papers/41507134PubMed
41444422SLC6A14-mediated glutamine promotes SYTL4-CXCL8 axis activation to drive gemcitabine resistance and immune evasion in pancreatic cancer.Exp Mol Med2025https://conductscience.org/library/papers/41444422PubMed
41131631USP21/YBX1/HIF1-α promotes the progression of prostate cancer.J Transl Med2025https://conductscience.org/library/papers/41131631PubMed
41070608Multifaceted functions of Y‑box binding protein 1 in RNA methylated modifications (Review).Mol Med Rep2025https://conductscience.org/library/papers/41070608PubMed
41029024YBX1 Enhances the Stability of TM4SF1 in an m5C-Dependent Manner to Promote Bladder Cancer Proliferation and Glycolysis.Comb Chem High Throughput Screen2026https://conductscience.org/library/papers/41029024PubMed
41025501YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas.Neuro Oncol2026https://conductscience.org/library/papers/41025501PubMed
40938464The functions and regulation of transcription factor YBX1 in cancers.Mol Biol Rep2025https://conductscience.org/library/papers/40938464PubMed
40814288The dual role of RNA-binding proteins: promotion of tumorigenesis, drug resistance, and emerging therapeutic targets.Acta Biochim Biophys Sin (Shanghai)2025https://conductscience.org/library/papers/40814288PubMed
40783393EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription.Cell Death Dis2025https://conductscience.org/library/papers/40783393PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
LRP14035PubTator's text mininghttps://conductscience.org/library/genes/4035NCBI Gene
RRM16240PubTator's text mininghttps://conductscience.org/library/genes/6240NCBI Gene
TCF36929PubTator's text mininghttps://conductscience.org/library/genes/6929NCBI Gene
YBX14904PubTator's text mininghttps://conductscience.org/library/genes/4904NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39216548

GET https://conductscience.org/api/papers/v1/39216548/authors